Company intelligence
Indero (formerly Innovaderm)
All in with your dermatology & rheumatology clinical development
About Indero (formerly Innovaderm)
Indero: Your Dual-Focus CRO for Dermatology & Rheumatology At Indero, we specialize in providing comprehensive Contract Research Organization (CRO) services for dermatology and rheumatology. Our team feels like an extension of your own, offering scientific guidance, accurate results, and exceptional customer satisfaction. Our Expertise: With over 25 years of deep medical and operational expertise in dermatology, we seamlessly translate our knowledge to rheumatology. We understand that dermatology and rheumatology are inextricably linked, as immune-mediated inflammatory skin and joint diseases often require similar treatments. Our Services: We set the standard with our value-added services, including: • Study Design and Protocol Development • Regulatory Submissions and Consulting • Trial Master Files Management • Project Management • Investigator/Site Selection • Patient Recruitment • Clinical and Medical Monitoring • Pharmacovigilance • Data Management and Biostatistical Analysis • Clinical Study Reports and Medical Writing Since 2000, Indero has built a strong reputation for the quality of our research and the care we offer to study participants, clients, and sites. We often exceed our clients' timeline expectations, ensuring successful outcomes for every project.
Verified activity
Signals from Indero (formerly Innovaderm)
4 published signals
Presence & Recognition
Indero (formerly Innovaderm) attended the ESDR meeting starting Wednesday in Heidelberg, Germany.
Reported by Indero (formerly Innovaderm)
Presence & Recognition
Indero (formerly Innovaderm) highlighted research advancing Alopecia and SkinCare on social media
Reported by Indero (formerly Innovaderm)
Presence & Recognition
Indero (formerly Innovaderm) is the only niche Rheumatology CRO for the month of September.
Reported by Indero (formerly Innovaderm)
Research & Knowledge
Indero (formerly Innovaderm) coauthored an analysis of 2,400 Icotrokinra-treated participants with psoriasis followed through 1 year, authored by Dr. Robert Bissonnette.
Reported by Indero (formerly Innovaderm)